GlassScriptPhysician profile
Ajit Janardhan
NPI 1518172279
$65,872.52
in general payments reported to CMS, 2019-2025
32 companies · $3,701 in 2025
The $3,701 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $4,473 · 2021: $18K · 2022: $14K · 2023: $4,295 · 2024: $1,481 · 2025: $3,701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,886 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,875 · Consulting Fee: $1,500 · Travel and Lodging: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,886.38 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,875.00 |
| Consulting Fee | $1,500.00 |
| Travel and Lodging | $215.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $25,500.00 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $24,040.21 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $4,586.81 | 2019-2025 | Versacross Access Solution, Accolade Sr, Farapulse |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $3,226.40 | 2019-2025 | Lifevest |
| Biosense Webster, INC. | $2,125.38 | 2019-2025 | Carto 3, Qdot Micro Catheter, Na |
| Altathera Pharmaceuticals LLC | $2,016.73 | 2025 | Sotalol Hydrochloride |
| Medtronic, INC. | $1,441.81 | 2021-2023 | Micra, Linq II |
| Cardiva Medical, INC. | $517.39 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f, Ensoetm |
| Abbott Laboratories | $478.01 | 2019-2025 | Amplatzer Amulet, Agilis |
| Impulse Dynamics (USA) INC. | $298.60 | 2023-2025 | Optimizer, Optimizer |
| Atricure, INC. | $242.52 | 2021-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Cvrx, INC. | $202.19 | 2020-2024 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $196.35 | 2019-2025 | |
| Shockwave Medical, INC | $151.24 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $147.47 | 2023-2025 | Camzyos |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $96.00 | 2021 | |
| Inspire Medical Systems, INC. | $94.63 | 2024 | Inspire |
| Merck Sharp & Dohme LLC | $81.92 | 2022-2024 | Verquvo |
| Lexicon Pharmaceuticals, INC. | $59.95 | 2023-2024 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.53 | 2024-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $48.20 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $43.88 | 2023 | Andexxa, Farxiga |
| Philips North America LLC | $30.72 | 2024 | (Ck4) Mcot |
| Janssen Scientific Affairs, LLC | $29.73 | 2022 | |
| Abiomed | $28.72 | 2020-2021 | |
| Pfizer INC. | $24.47 | 2023 | |
| Novo Nordisk INC | $21.44 | 2022 | |
| Kestra Medical Technology Services, INC. | $21.32 | 2025 | Assure Wcd |
| Medtronic Vascular, INC. | $20.33 | 2020 | |
| Ethicon US, LLC | $17.69 | 2022 | |
| Merit Medical Systems INC | $15.88 | 2024 | Prelude Introducers, Safeguard Focus |
| Sanofi-Aventis U.S. LLC | $13.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajit Janardhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.